ALNY: Alnylam Pharmaceuticals, Inc. Stock

by  •  • Comments Off on ALNY: Alnylam Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 32,122.20
Enterprise Value ($M) 33,627.77
Book Value ($M) 67.09
Book Value / Share 0.52
Price / Book 478.81
NCAV ($M) -877.61
NCAV / Share -6.78
Price / NCAV -36.60

Profitability (mra)
Return on Invested Capital (ROIC) -0.10
Return on Assets (ROA) -0.07
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 2.71
Current Ratio 2.78

Balance Sheet (mrq) ($M)
Current Assets 3,295.28
Assets 4,239.98
Liabilities 4,172.90
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2,248.24
Operating Income -176.88
Net Income -278.16
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -8.31
Cash from Investing -116.84
Cash from Financing 294.16

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G Capital Research Global Investors 5.40
11-12 13G/A Fmr Llc 11.48 11.23
11-08 13G/A Wellington Management Group Llp 3.91 -30.80
07-05 13G/A Baillie Gifford & Co 4.77 -13.41
2024-02-13 13G/A Vanguard Group Inc 9.52 3.80
2024-02-09 13G/A Capital World Investors 13.10 -1.18

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ____________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended Ma

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 116,885 371,598 31.45
2025-03-06 92,455 452,614 20.43
2025-03-05 95,363 433,297 22.01
2025-03-04 102,127 463,594 22.03

(click for more detail)

Similar Companies
ALKS – Alkermes plc ALLK – Allakos Inc.
ALLO – Allogene Therapeutics, Inc. ALXO – ALX Oncology Holdings Inc.
AMGN – Amgen Inc.


Financial data and stock pages provided by
Fintel.io